XURIDEN (URIDINE TRIACETATE) — FDA Approval NDA208169 (BTG INTL)
XURIDEN (URIDINE TRIACETATE) — FDA Approval NDA208169 (BTG INTL) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: XURIDEN; Active ingredients: URIDINE TRIACETATE; Application number: NDA208169.
| Brand name | XURIDEN |
|---|---|
| Active ingredients | URIDINE TRIACETATE |
| Application number | NDA208169 |
| Sponsor | BTG INTL |
| Dosage form | GRANULE |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 1 |
| First approval date | 20150904 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →